Clinical Trial Update: Evaluation of Pneumococcal Vaccine Formulations in Young Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pneumococcal vaccine formulations in young adults has completed. Sponsor: GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pneumococcal vaccine formulations (Streptococcus pneumoniae vaccine formulations)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 1 | Status: COMPLETED